The impact of GLP-1 receptor agonist shortages on glycaemic Control: Findings from an Australian specialist diabetes clinic

IF 6.1 3区医学 Q1 ENDOCRINOLOGY & METABOLISM

Diabetes research and clinical practice Pub Date : 2024-06-07 DOI:10.1016/j.diabres.2024.111740

Natalie Nanayakkara , Michael LH Huang , Alicia J Jenkins , Neale D Cohen

引用次数: 0

Abstract

There have been shortages of glucagon-like peptide-1 receptor agonists (GLP-1 RA) for type 2 diabetes (T2D) care. Analyses of data from 811 T2D adults at an Australian specialist diabetes clinic (1/2019–10/2023) who received ≥ 2 GLP-1 RA prescriptions before and during the shortage showed median HbA1c levels significantly increased by 0.3 %.

查看原文本刊更多论文

GLP-1 受体激动剂短缺对血糖控制的影响：澳大利亚糖尿病专科诊所的研究结果

用于 2 型糖尿病（T2D）治疗的胰高血糖素样肽-1 受体激动剂（GLP-1 RA）曾出现过短缺。对澳大利亚一家糖尿病专科诊所（2019 年 1 月至 2023 年 10 月）811 名成人 2 型糖尿病患者的数据进行了分析，这些患者在药物短缺前和短缺期间接受了≥ 2 次 GLP-1 RA 处方治疗，结果显示 HbA1c 水平中位数显著增加了 0.3%。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetes research and clinical practice 医学-内分泌学与代谢

CiteScore

10.30

自引率

3.90%

发文量

862

审稿时长

32 days

期刊介绍： Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.